News
Makwana Solicitors ( has successfully brought a regulatory compliance matter to a close within days of instruction, securing a positive outcome for a small business client under investigation by the ...
There are over 52,000 cases of prostate cancer each year in the UK alone ... available in England for eligible patients following marketing authorisation from the MHRA. This follows the initial ...
In dawn raids in four counties across the West Midlands and Northwest of England this morning ... and Healthcare products Regulatory Agency (MHRA). The arrests were made on suspicion of ...
2d
inews.co.uk on MSNInterest in weight-loss jabs is surging – here’s what semaglutide does to your bodyAvailable by prescription (Xenical) and over the counter (Alli), it is often used with a low-fat diet. While effective, ...
“We're pleased to recommend linzagolix as a new treatment option for endometriosis. As a once-daily tablet taken at home, it offers a convenient way for people with endometriosis to manage their ...
United Kingdom Friday, May 2, 2025, 11:00 Hrs [IST] An innovative vaccine that doesn’t need to be refrigerated or frozen has ...
A 12-year-old Newry boy living with Duchenne Muscular Dystrophy (DMD) has had the opportunity to meet with Northern Ireland’s ...
Bavarian Nordic A/S, a global vaccine company, announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization in the United Kingdom (UK) for ...
according to NHS England. The MHRA’s decision was based on results from the phase 3 CheckMate-67T trial, in which SC Opdivo produced comparable levels of drug in the body and a similar safety and ...
Makwana Solicitors (www.makwanas.co.uk) has successfully brought a regulatory compliance ... under investigation by the Medicines and Healthcare Products Regulatory Agency (MHRA). The client, a young ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Bavarian Nordic's Vimkunya (recombinant, adsorbed) vaccine for preventing chikungunya virus ...
The Court of Appeal has upheld a British watchdog's 99 million pound ($131.94 million) fine against owners of Advanz Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results